1. Home
  2. RVMD vs CHYM Comparison

RVMD vs CHYM Comparison

Compare RVMD & CHYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • CHYM
  • Stock Information
  • Founded
  • RVMD 2014
  • CHYM 2012
  • Country
  • RVMD United States
  • CHYM United States
  • Employees
  • RVMD N/A
  • CHYM N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • CHYM Finance: Consumer Services
  • Sector
  • RVMD Health Care
  • CHYM Finance
  • Exchange
  • RVMD Nasdaq
  • CHYM Nasdaq
  • Market Cap
  • RVMD 7.5B
  • CHYM 7.0B
  • IPO Year
  • RVMD 2020
  • CHYM 2025
  • Fundamental
  • Price
  • RVMD $65.84
  • CHYM $20.35
  • Analyst Decision
  • RVMD Strong Buy
  • CHYM Buy
  • Analyst Count
  • RVMD 17
  • CHYM 14
  • Target Price
  • RVMD $77.24
  • CHYM $32.85
  • AVG Volume (30 Days)
  • RVMD 2.4M
  • CHYM 4.4M
  • Earning Date
  • RVMD 11-05-2025
  • CHYM 11-05-2025
  • Dividend Yield
  • RVMD N/A
  • CHYM N/A
  • EPS Growth
  • RVMD N/A
  • CHYM N/A
  • EPS
  • RVMD N/A
  • CHYM N/A
  • Revenue
  • RVMD N/A
  • CHYM $2,065,624,000.00
  • Revenue This Year
  • RVMD N/A
  • CHYM $31.00
  • Revenue Next Year
  • RVMD $537.73
  • CHYM $20.53
  • P/E Ratio
  • RVMD N/A
  • CHYM N/A
  • Revenue Growth
  • RVMD N/A
  • CHYM 30.88
  • 52 Week Low
  • RVMD $29.17
  • CHYM $16.17
  • 52 Week High
  • RVMD $65.98
  • CHYM $44.94
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 84.78
  • CHYM N/A
  • Support Level
  • RVMD $58.91
  • CHYM N/A
  • Resistance Level
  • RVMD $63.15
  • CHYM N/A
  • Average True Range (ATR)
  • RVMD 2.19
  • CHYM 0.00
  • MACD
  • RVMD 0.40
  • CHYM 0.00
  • Stochastic Oscillator
  • RVMD 98.46
  • CHYM 0.00

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About CHYM Chime Financial Inc. Class A Common Stock

Chime Financial Inc is a financial technology company that believes in core banking services.

Share on Social Networks: